Business
Currency:CNY
2024/FY
Stock NameRevenueRatio
许可收入33.52M48.36%
销售眼科药物30.44M43.91%
Sale of other drugs2.15M3.10%
销售眼科产品2M2.89%
独家分销权收入1.2M1.74%
Product
Currency:CNY
2024/FY
Stock NameRevenueRatio
许可收入33.52M48.36%
销售眼科药物30.44M43.91%
Sale of other drugs2.15M3.10%
销售眼科产品2M2.89%
独家分销权收入1.2M1.74%
Region
Currency:CNY
2024/H1
Stock NameRevenueRatio
Chinese mainland48.71M97.88%
South Korea598K1.20%
Hong Kong (location)457K0.92%